Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Karen Rascati

TitleLecturer
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-Extended Studies Program

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Alefan Q, Rascati K. PHARMACOECONOMIC STUDIES IN WORLD HEALTH ORGANIZATION EASTERN MEDITERRANEAN COUNTRIES: REPORTING COMPLETENESS. Int J Technol Assess Health Care. 2017 Jun 05; 1-7. PMID: 28578712.
      View in: PubMed
    2. Rascati K. Comment on: "Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode". Drugs R D. 2017 May 20. PMID: 28528515.
      View in: PubMed
    3. Wong SL, Barner JC, Sucic K, Nguyen M, Rascati KL. Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas. J Am Pharm Assoc (2003). 2017 May - Jun; 57(3):375-381. PMID: 28506398.
      View in: PubMed
    4. Rascati KL, Worley K, Meah Y, Everhart D. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 Inhibitors. J Manag Care Spec Pharm. 2017 Mar; 23(3):299-306. PMID: 28230454.
      View in: PubMed
    5. Heo JH, Rascati KL, Lee EK. Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea. Value Health Reg Issues. 2017 May; 12:7-19. PMID: 28648319.
      View in: PubMed
    6. Tran M, Xiang P, Rascati KL, Stock EM, Godley PJ, Coleman A, Bogart MR, Stanford RH. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission. J Manag Care Spec Pharm. 2016 Oct; 22(10):1186-93. PMID: 27668567.
      View in: PubMed
    7. Kim-Romo DN, Rascati KL, Richards KM, Ford KC, Wilson JP, Beretvas SN. Medication Adherence and Persistence in Patients with Severe Major Depressive Disorder with Psychotic Features: Antidepressant and Second-Generation Antipsychotic Therapy Versus Antidepressant Monotherapy. J Manag Care Spec Pharm. 2016 May; 22(5):588-96. PMID: 27123919.
      View in: PubMed
    8. Hinds A, Lopez D, Rascati K, Jokerst J, Srinivasa M. Adherence to the 2013 Blood Cholesterol Guidelines in Patients With Diabetes at a PCMH: Comparison of Physician Only and Combination Physician/Pharmacist Visits. Diabetes Educ. 2016 Apr; 42(2):228-33. PMID: 26902526.
      View in: PubMed
    9. Kim G, Barner JC, Rascati K, Richards K. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis. Clin Ther. 2016 Mar; 38(3):646-54. PMID: 26899313.
      View in: PubMed
    10. Ko JJ, Lu J, Rascati K, Stock EM, Juan J, Suh K, Kim Y, Tabor PA, Godley PJ. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes. J Manag Care Spec Pharm. 2016 Jan; 22(1):32-7. PMID: 27015049.
      View in: PubMed
    11. Makhinova T, Barner JC, Richards KM, Rascati KL. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma. J Manag Care Spec Pharm. 2015 Dec; 21(12):1124-32. PMID: 26679962.
      View in: PubMed
    12. Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC. Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis. J Manag Care Spec Pharm. 2015 Oct; 21(10):956-64. PMID: 26402394.
      View in: PubMed
    13. Park H, Rascati KL, Keith MS. Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations. J Manag Care Spec Pharm. 2015 Jun; 21(6):507-14. PMID: 26011552.
      View in: PubMed
    14. Park H, Adeyemi AO, Rascati KL. Direct Medical Costs and Utilization of Health Care Services to Treat Pneumonia in the United States: An Analysis of the 2007-2011 Medical Expenditure Panel Survey. Clin Ther. 2015 Jul 01; 37(7):1466-1476.e1. PMID: 26001310.
      View in: PubMed
    15. Kim G, Barner JC, Rascati K, Richards K. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis. J Manag Care Spec Pharm. 2015 May; 21(5):401-7. PMID: 25943001.
      View in: PubMed
    16. Scalo J, Desai P, Rascati K. Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample. Qual Life Res. 2015 May; 24(5):1223-33. PMID: 25432884.
      View in: PubMed
    17. Shcherbakova N, Rascati K, Brown C, Lawson K, Novak S, Richards KM, Yoder L. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims. CNS Drugs. 2014 Nov; 28(11):1047-58. PMID: 25086640.
      View in: PubMed
    18. Chung N, Rascati K, Lopez D, Jokerst J, Garza A. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population. J Manag Care Spec Pharm. 2014 Sep; 20(9):914-9. PMID: 25166290.
      View in: PubMed
    19. Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase. J Manag Care Spec Pharm. 2014 Aug; 20(8):862-76. PMID: 25062080.
      View in: PubMed
    20. Oladapo A, Barner JC, Lawson KA, Novak S, Rascati KL, Richards KM, Harrison DJ. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis. J Manag Care Spec Pharm. 2014 Jul; 20(7):657-67. PMID: 24967519.
      View in: PubMed
    21. Scalo JF, Rascati KL. Trends and issues in oncology costs. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb; 14(1):35-44. PMID: 24328809.
      View in: PubMed
    22. Makhinova T, Rascati K. Pharmacoeconomics education in US colleges and schools of pharmacy. Am J Pharm Educ. 2013 Sep 12; 77(7):145. PMID: 24052648; PMCID: PMC3776899.
    23. Chandwani HS, Strassels SA, Rascati KL, Lawson KA, Wilson JP. Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events. J Pain Palliat Care Pharmacother. 2013 Aug; 27(3):206-13. PMID: 23879214.
      View in: PubMed
    24. Desai PR, Lawson KA, Barner JC, Rascati KL. Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients. J Manag Care Pharm. 2013 Jul-Aug; 19(6):468-77. PMID: 23806061.
      View in: PubMed
    25. Gavaza P, Rascati KL, Oladapo AO, Khoza S. The authors' reply to Gow et al.: "the state of health economic research in South Africa". Pharmacoeconomics. 2013 Mar; 31(3):255-6. PMID: 23430608.
      View in: PubMed
    26. Park H, Park C, Kim Y, Rascati KL. Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis. Ann Pharmacother. 2012 Nov; 46(11):1453-69. PMID: 23136353.
      View in: PubMed
    27. Oladapo AO, Barner JC, Rascati KL. The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services. Clin Ther. 2012 Nov; 34(11):2196-9. PMID: 23149006.
      View in: PubMed
    28. Gavaza P, Rascati KL, Oladapo AO, Khoza S. The state of health economic research in South Africa: a systematic review. Pharmacoeconomics. 2012 Oct 01; 30(10):925-40. PMID: 22809450.
      View in: PubMed
    29. Gavaza P, Brown CM, Lawson KA, Rascati KL, Steinhardt M, Wilson JP. Effect of social influences on pharmacists' intention to report adverse drug events. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):622-9. PMID: 23023842.
      View in: PubMed
    30. Desai PR, Chandwani HS, Rascati KL. Assessing the quality of pharmacoeconomic studies in India: a systematic review. Pharmacoeconomics. 2012 Sep 01; 30(9):749-62. PMID: 22720697.
      View in: PubMed
    31. Cheng LI, Rascati KL. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008. Arthritis Care Res (Hoboken). 2012 Sep; 64(9):1423-9. PMID: 22508663.
      View in: PubMed
    32. Gavaza P, Brown CM, Lawson KA, Rascati KL, Steinhardt M, Wilson JP. Pharmacist reporting of serious adverse drug events to the Food and Drug Administration. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e109-12. PMID: 23023857.
      View in: PubMed
    33. Oladapo AO, Rascati KL. Review of survey articles regarding medication therapy management (MTM) services/programs in the United States. J Pharm Pract. 2012 Aug; 25(4):457-70. PMID: 22544620.
      View in: PubMed
    34. Tiwana SK, Rascati KL, Park H. Cost-effectiveness of expanded newborn screening in Texas. Value Health. 2012 Jul-Aug; 15(5):613-21. PMID: 22867769.
      View in: PubMed
    35. Park H, Rascati KL, Prasla K, McBayne T. Evaluation of health care costs and utilization patterns for patients with gout. Clin Ther. 2012 Mar; 34(3):640-52. PMID: 22381710.
      View in: PubMed
    36. Oladapo AO, Barner JC, Rascati KL, Strassels SA. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Clin Ther. 2012 Mar; 34(3):605-13. PMID: 22386828.
      View in: PubMed
    37. Adeyemi AO, Rascati KL, Lawson KA, Strassels SA. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis. Clin Ther. 2012 Mar; 34(3):712-9. PMID: 22381712.
      View in: PubMed
    38. Koranek AM, Smith TL, Mican LM, Rascati KL. Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility. Schizophr Res. 2012 May; 137(1-3):137-40. PMID: 22364675.
      View in: PubMed
    39. Khoza S, Barner JC, Bohman TM, Rascati K, Lawson K, Wilson JP. Use of antidepressants and the risk of type 2 diabetes mellitus: a nested case-control study. Int J Clin Pharm. 2012 Jun; 34(3):432-8. PMID: 22249783.
      View in: PubMed
    40. Rascati KL, Richards KM, Lopez D, Cheng LI, Wilson JP. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database. Clin Ther. 2011 Dec; 33(12):2016-20. PMID: 22101160.
      View in: PubMed
    41. Rascati KL, Richards KM, Ott CA, Goddard AW, Stafkey-Mailey D, Alvir J, Sanders KN, Mychaskiw M. Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatr Serv. 2011 Sep; 62(9):1032-40. PMID: 21885581.
      View in: PubMed
    42. Park H, Rascati KL, Keith MS, Hodgkins P, Smyth M, Goldsmith D, Akehurst R. Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective. Value Health. 2011 Dec; 14(8):1002-9. PMID: 22152168.
      View in: PubMed
    43. Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol. 2011 Jul; 72(1):143-52. PMID: 21332572; PMCID: PMC3141196.
    44. Kim YA, Rascati KL, Prasla K, Godley P, Goel N, Dunlop D. Retrospective evaluation of the impact of copayment increases for specialty medications on adherence and persistence in an integrated health maintenance organization system. Clin Ther. 2011 May; 33(5):598-607. PMID: 21665044.
      View in: PubMed
    45. Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration. J Am Pharm Assoc (2003). 2011 May-Jun; 51(3):397-403. PMID: 21555292.
      View in: PubMed
    46. Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Social Adm Pharm. 2011 Dec; 7(4):369-82. PMID: 21272531.
      View in: PubMed
    47. Adeyemi A, Rascati K, Strassels S. The need for oral antidiabetic treatment adherence studies in the pediatric population. Clin Ther. 2010 Jul; 32(7):1306-7. PMID: 20678678.
      View in: PubMed
    48. Barnes JN, Rascati KL. Switching of antiepileptic drug formulations. J Pediatr Pharmacol Ther. 2010 Apr; 15(2):64-5. PMID: 22477795; PMCID: PMC3018181.
    49. Gavaza P, Rascati KL, Oladapo AO, Khoza S. The state of health economic evaluation research in Nigeria: a systematic review. Pharmacoeconomics. 2010; 28(7):539-53. PMID: 20550221.
      View in: PubMed
    50. Cheng LI, Oladapo A, Rascati KL. The need for validation studies of comorbidity adjustment instruments. Clin Ther. 2009 Jul; 31(7):1578-80. PMID: 19695407.
      View in: PubMed
    51. Rascati KL, Richards KM, Johnsrud MT, Mann TA. Effects of antiepileptic drug substitutions on epileptic events requiring acute care. Pharmacotherapy. 2009 Jul; 29(7):769-74. PMID: 19558250.
      View in: PubMed
    52. Brown CM, Nwokeji E, Rascati KL, Zachry W, Phillips GA. Development of the burden of prior authorization of psychotherapeutics (BoPAP) scale to assess the effects of prior authorization among Texas Medicaid providers. Adm Policy Ment Health. 2009 Jul; 36(4):278-87. PMID: 19350379.
      View in: PubMed
    53. Yang M, Barner JC, Lawson KA, Rascati KL, Wilson JP, Crismon ML, Worchel J, Mascarenas CA. Antipsychotic medication utilization trends among Texas veterans: 1997-2002. Ann Pharmacother. 2008 Sep; 42(9):1229-38. PMID: 18682544.
      View in: PubMed
    54. Reddy M, Rascati K, Wahawisan J, Rascati M. Pharmacoeconomic education in US colleges and schools of pharmacy: an update. Am J Pharm Educ. 2008 Jun 15; 72(3):51. PMID: 18698384; PMCID: PMC2508714.
    55. Gavaza P, Rascati K, Brown C, Lawson K, Mann T. The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review. Curr Ther Res Clin Exp. 2008 Jun; 69(3):268-85. PMID: 24692805; PMCID: PMC3969967.
    56. Yarger S, Rascati K, Lawson K, Barner J, Leslie R. Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in Texas. Clin Ther. 2008; 30 Spec No:1051-7. PMID: 18640479.
      View in: PubMed
    57. Brown CM, Richards K, Rascati KL, Gavaza P, Corbell Z, Zachry W, Phillips GA. Effects of a psychotherapeutic drug prior authorization (PA) requirement on patients and providers: a providers' perspective. Adm Policy Ment Health. 2008 May; 35(3):181-8. PMID: 18064560.
      View in: PubMed
    58. Nwokeji ED, Rascati KL, Moczygemba LR, Wilson JP. Pharmacoepidemiology education in US colleges and schools of pharmacy. Am J Pharm Educ. 2007 Aug 15; 71(4):80. PMID: 17786268; PMCID: PMC1959224.
    59. Rascati KL, Moczygemba LR. The need for pharmacoeconomic studies of pharmacy services. Clin Ther. 2007 Jul; 29(7):1488-90. PMID: 17825700.
      View in: PubMed
    60. Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clin Ther. 2007 Jun; 29(6):1203-13. PMID: 17692734.
      View in: PubMed
    61. Nwokeji ED, Rascati KL, Brown CM, Eisenberg A. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain. Clin Ther. 2007; 29 Suppl:2589-602. PMID: 18164924.
      View in: PubMed
    62. Rascati KL. The $64,000 question--what is a quality-adjusted life-year worth? Clin Ther. 2006 Jul; 28(7):1042-3. PMID: 16990082.
      View in: PubMed
    63. Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Saf. 2006; 29(7):621-32. PMID: 16808554.
      View in: PubMed
    64. Patel NC, Crismon ML, Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP. Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program. Med Care. 2006 Jan; 44(1):87-90. PMID: 16365617.
      View in: PubMed
    65. Smith MJ, Rascati KL, Barner JC. A descriptive analysis of asthma-related medical services and prescription utilization among recipients in a Medicaid program. J Asthma. 2005 Jul-Aug; 42(6):447-53. PMID: 16293539.
      View in: PubMed
    66. Patel NC, Crismon ML, Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP, Jensen PS. Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2005 Jun; 44(6):548-56. PMID: 15908837.
      View in: PubMed
    67. Rascati KL, Stanford RH, Borker R. A comparison of the risk of hospitalizations due to chronicobstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combination. Clin Ther. 2005 Mar; 27(3):346-54. PMID: 15878389.
      View in: PubMed
    68. Opolka JL, Rascati KL, Brown CM, Gibson PJ. Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine. Psychiatr Serv. 2004 Feb; 55(2):151-6. PMID: 14762239.
      View in: PubMed
    69. Smith MJ, Rascati KL, McWilliams BC. Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program. Ann Allergy Asthma Immunol. 2004 Jan; 92(1):40-6. PMID: 14756463.
      View in: PubMed
    70. Rascati KL, Drummond MF, Annemans L, Davey PG. Education in pharmacoeconomics: an international multidisciplinary view. Pharmacoeconomics. 2004; 22(3):139-47. PMID: 14871162.
      View in: PubMed
    71. Opolka JL, Rascati KL, Brown CM, Barner JC, Johnsrud MT, Gibson PJ. Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia. J Clin Psychiatry. 2003 Jun; 64(6):635-9. PMID: 12823076.
      View in: PubMed
    72. Opolka JL, Rascati KL, Brown CM, Gibson PJ. Role of ethnicity in predicting antipsychotic medication adherence. Ann Pharmacother. 2003 May; 37(5):625-30. PMID: 12708934.
      View in: PubMed
    73. Rascati KL, Johnsrud MT, Crismon ML, Lage MJ, Barber BL. Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients. Pharmacoeconomics. 2003; 21(10):683-97. PMID: 12828491.
      View in: PubMed
    74. Balkrishnan R, Camacho FT, Smith BP, Shilt JS, Jacks LK, Koman LA, Rascati KL, Mooney JF. Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy. J South Orthop Assoc. 2002; 11(2):71-9. PMID: 12741586.
      View in: PubMed
    Rascati's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)